These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 16908209

  • 1. The correlation of the IGF-I, IGFBP-3, and ALS generation test to height velocity after 6 months of recombinant growth hormone therapy in girls with Turner syndrome.
    Collett-Solberg PF, Pessoa de Queiroz AN, Cardoso ME, Jusan RC, Vaisman M, Guimarães MM.
    Growth Horm IGF Res; 2006 Aug; 16(4):240-6. PubMed ID: 16908209
    [Abstract] [Full Text] [Related]

  • 2. IGF-I, IGFBP-3 and ALS generation test in Turner syndrome.
    Pessoa de Queiroz AN, Collett-Solberg PF, Cardoso ME, Jusan RC, Vaisman M, Guimarães MM.
    Growth Horm IGF Res; 2007 Jun; 17(3):254-60. PubMed ID: 17540594
    [Abstract] [Full Text] [Related]

  • 3. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
    Bannink EM, van Doorn J, Stijnen T, Drop SL, de Muinck Keizer-Schrama SM.
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
    [Abstract] [Full Text] [Related]

  • 4. The GH-IGF-IGFBP axis is changed in Turner syndrome: partial normalization by HRT.
    Gravholt CH, Chen JW, Oxvig C, Overgaard MT, Christiansen JS, Frystyk J, Flyvbjerg A.
    Growth Horm IGF Res; 2006 Sep; 16(5-6):332-9. PubMed ID: 17067837
    [Abstract] [Full Text] [Related]

  • 5. Plasma growth hormone-binding protein activity, insulin-like growth factor I, and its binding protein levels in patients with Turner's syndrome: effect of short- and long-term recombinant human growth hormone administration.
    Saggese G, Federico G, Cinquanta L.
    Pediatr Res; 1995 Jan; 37(1):106-11. PubMed ID: 7535419
    [Abstract] [Full Text] [Related]

  • 6. Insulin-like growth factor I and growth responses during the first year of growth hormone treatment in KIGS patients with idiopathic growth hormone deficiency, acquired growth hormone deficiency, turner syndrome and born small for gestational age.
    Cutfield WS, Lundgren F.
    Horm Res; 2009 Jan; 71 Suppl 1():39-45. PubMed ID: 19153504
    [Abstract] [Full Text] [Related]

  • 7. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.
    Binder G, Baur F, Schweizer R, Ranke MB.
    J Clin Endocrinol Metab; 2006 Feb; 91(2):659-64. PubMed ID: 16291706
    [Abstract] [Full Text] [Related]

  • 8. Normal growth spurt and final height despite low levels of all forms of circulating insulin-like growth factor-I in a patient with acid-labile subunit deficiency.
    Domené HM, Martínez AS, Frystyk J, Bengolea SV, Ropelato MG, Scaglia PA, Chen JW, Heuck C, Wolthers OD, Heinrich JJ, Jasper HG.
    Horm Res; 2007 Feb; 67(5):243-9. PubMed ID: 17213728
    [Abstract] [Full Text] [Related]

  • 9. Serum leptin and IGF-I during growth hormone treatment in chronic renal failure.
    Patel L, Webb NJ, Bradbury MG, Zaman N, Smith P, Lewis MA, Postlethwaite RJ, Price DA, Clayton PE.
    Pediatr Nephrol; 2002 Aug; 17(8):643-7. PubMed ID: 12185474
    [Abstract] [Full Text] [Related]

  • 10. Growth hormone in turner syndrome.
    Khadilkar VV, Khadilkar AV, Nandy M, Maskati GB.
    Indian Pediatr; 2006 Mar; 43(3):236-40. PubMed ID: 16585818
    [Abstract] [Full Text] [Related]

  • 11. Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. Dutch Working Group on Growth Hormone.
    van Teunenbroek A, de Muinck Keizer-Schrama SM, Stijnen T, Jansen M, Otten BJ, Delemarre-van de Waal HA, Vulsma T, Wit JM, Rouwé CW, Reeser HM, Gosen JJ, Rongen-Westerlaken C, Drop SL.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4013-21. PubMed ID: 8923853
    [Abstract] [Full Text] [Related]

  • 12. Effects of growth hormone on growth, insulin resistance and related hormones (ghrelin, leptin and adiponectin) in Turner syndrome.
    Darendeliler F, Aycan Z, Cetinkaya E, Vidilisan S, Bas F, Bideci A, Demirel F, Darcan S, Buyukgebiz A, Yildiz M, Berberoglu M, Arslanoglu I, Bundak R.
    Horm Res; 2007 Nov; 68(1):1-7. PubMed ID: 17204837
    [Abstract] [Full Text] [Related]

  • 13. Changes of thyroid function during long-term hGH therapy in GHD children. A possible relationship with catch-up growth?
    Seminara S, Stagi S, Candura L, Scrivano M, Lenzi L, Nanni L, Pagliai F, Chiarelli F.
    Horm Metab Res; 2005 Dec; 37(12):751-6. PubMed ID: 16372229
    [Abstract] [Full Text] [Related]

  • 14. [Prediction of final height in girls with Turner syndrome treated with growth hormone].
    Morin A, Guimarey L, Santucci Z, Apezteguia M.
    Medicina (B Aires); 2000 Dec; 60(5 Pt 1):551-4. PubMed ID: 11188890
    [Abstract] [Full Text] [Related]

  • 15. Growth hormone bioactivity in girls with Turner's syndrome: correlation with insulin-like growth factor I.
    Foster CM, Borondy M, Markovs ME, Hopwood NJ, Kletter GB, Beitins IZ.
    Pediatr Res; 1994 Feb; 35(2):218-22. PubMed ID: 7513079
    [Abstract] [Full Text] [Related]

  • 16. Changes in growth pattern, body composition and biochemical markers of growth after adenotonsillectomy in prepubertal children.
    Ersoy B, Yücetürk AV, Taneli F, Urk V, Uyanik BS.
    Int J Pediatr Otorhinolaryngol; 2005 Sep; 69(9):1175-81. PubMed ID: 15885810
    [Abstract] [Full Text] [Related]

  • 17. Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome.
    Blum WF, Cao D, Hesse V, Fricke-Otto S, Ross JL, Jones C, Quigley CA, Binder G.
    Horm Res; 2009 Sep; 71(3):167-72. PubMed ID: 19188742
    [Abstract] [Full Text] [Related]

  • 18. [Growth hormone for Turner's syndrome].
    Fishman A, Hochberg Z.
    Harefuah; 1991 Nov 01; 121(9):281-6. PubMed ID: 1800273
    [Abstract] [Full Text] [Related]

  • 19. The exon 3-deleted/full-length growth hormone receptor polymorphism and response to growth hormone therapy in growth hormone deficiency and Turner syndrome: a multicenter study.
    Baş F, Darendeliler F, Aycan Z, Çetinkaya E, Berberoğlu M, Sıklar Z, Öcal G, Timirci Ö, Çetinkaya S, Darcan Ş, Gökşen Şimşek D, Bideci A, Cinaz P, Böber E, Demir K, Bereket A, Turan S, Atabek ME, Tütüncüler F, Isbir T, Bozkurt N, Kabataş Eryılmaz S, Uzunhan O, Küçükemre Aydın B, Bundak R.
    Horm Res Paediatr; 2012 Nov 01; 77(2):85-93. PubMed ID: 22456308
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the components of the insulin-like growth factors system in GH-deficient adults: effects of twelve-month rhGH treatment.
    Ferrante E, Giavoli C, Porretti S, Vassallo E, Ronchi CL, Lania AG, Beck-Peccoz P, Spada A.
    Horm Metab Res; 2006 May 01; 38(5):352-5. PubMed ID: 16718634
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.